Todd M. DuChene, serving as the Chief Legal and Administrative Officer at Core Scientific, Inc. (NASDAQ: CORZ), executed a sale of 10,000 shares of the company's common stock on July 13, 2026. The transaction resulted in total proceeds of $224,474. The shares were divested at prices fluctuating between $22.4301 and $23.01 per share. This insider activity follows a period where Core Scientific's stock has appreciated by 65% over the trailing twelve months. Despite this upward trajectory, valuation metrics suggest the equity may be trading at a premium relative to its calculated fair value. The firm currently holds a market capitalization of $7.02 billion.
The disposition of shares was structured across two distinct blocks to facilitate the transaction. In the initial block, DuChene offloaded 9,700 shares at a weighted average price of $22.4301 per share. These specific shares were traded in multiple executions with prices ranging from $21.91 to $22.89. A secondary block involved the sale of 300 shares at a weighted average price of $23.01 per share. Individual transactions within this second block occurred at prices between $22.97 and $23.04.
All reported sales were conducted pursuant to a Rule 10b5-1 trading plan, a mechanism designed to allow executives to trade shares without the appearance of insider trading. DuChene originally adopted this pre-arranged plan on December 5, 2025. Following the completion of these transactions, DuChene's direct ownership in Core Scientific common stock stands at 2,013,426 shares.
Concurrent with the insider activity, Core Scientific has attracted attention from multiple financial analysts and is undergoing significant operational changes. Research firm BTIG upgraded its outlook for the company, raising its price target to $33 while maintaining a Buy rating. This adjustment followed Core Scientific's expansion of power capacity by approximately 1.2 gigawatts. The expansion includes a new 430-megawatt site located in Hunt County, Texas.
Lucid Capital Markets initiated coverage on Core Scientific with a Buy rating, setting a price target of $40. The firm cited the company's unique position as a Bitcoin-to-HPC converter as a key driver. Meanwhile, Freedom Broker began coverage with a Hold rating, emphasizing Core Scientific's potential to serve as a high-density colocation host for artificial intelligence data centers.
In corporate governance developments, Core Scientific appointed Steve Smith to its board of directors. Smith, who also serves as the CEO of Zayo Group, brings over 35 years of experience in data centers and digital infrastructure. Additionally, at the company's 2026 Annual Meeting of Stockholders, five board members were elected to serve until the 2027 meeting. These governance changes reflect the company's strategic focus on infrastructure growth and operational scaling.